TITLE

Identification, frequency, activation and function of CD4+ CD25FoxP3+ regulatory T cells in children with juvenile idiopathic arthritis

AUTHOR(S)
Stelmaszczyk-Emmel, Anna; Jackowska, Teresa; Rutkowska-Sak, Lidia; Marusak-Banacka, Maria; Wąsik, Maria
PUB. DATE
May 2012
SOURCE
Rheumatology International;May2012, Vol. 32 Issue 5, p1147
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The aim of the study was to test the frequency of CD4+ CD25FoxP3 regulatory T cells in JIA patients and to assess their activation status and functional activity. The study involved 12 children with JIA and 35 healthy control subjects. PBMC were stained with monoclonal antibodies (anti-CD25, anti-CD4, anti-CD127, anti-CD69, anti-CD71, and anti-FoxP3). The samples were evaluated using flow cytometer. CD4+ CD25− and CD4+ CD25+ cells were isolated by negative and positive selection with magnetic microbeads. CD4+ CD25+ and CD4+ CD25− cells were cultured separately and co-cultured (1:1) with or without PHA. The percentage of Tregs in JIA patients was significantly decreased in comparison with controls (median, 3.2 vs. 4.6; P = 0.042). Relative fluorescence intensities of FoxP3 were higher in JIA patients than in controls (median, 9.1 vs. 6.8). The percentage of activated Tregs (CD71+) was significantly higher in JIA patients in comparison with controls (median, 6.5 vs. 2.8; P = 0.00043). CD4+ CD25+ cells derived from JIA patients and controls were anergic upon PHA stimulation, while CD4+ CD25− cells showed intensive proliferative response. The proliferation rate of CD4+ CD25− cells stimulated by PHA was decreased in co-cultures. In JIA patients, the inhibition of proliferation of CD4+ CD25− cells by CD4+ CD25+ cells was 37.9%, whereas in controls it was significantly lower (55.7%, P = 0.046). JIA patients had statistically lower percentage of Tregs in peripheral blood compared to controls. CD4+ CD25+ cells sorted from peripheral blood of JIA patients had statistically lower ability to suppress CD4+ CD25− cell proliferation in comparison with cells obtained from controls.
ACCESSION #
74550671

 

Related Articles

  • monoclonal antibody.  // Taber's Cyclopedic Medical Dictionary (2009);2009, Issue 21, p1486 

    An encyclopedia entry for "monoclonal antibody," which refers to the antibody which is specific to a certain antigen, is presented.

  • A Humanized Anti-VEGF Rabbit Monoclonal Antibody Inhibits Angiogenesis and Blocks Tumor Growth in Xenograft Models. Yanlan Yu; Pierre Lee; Yaohuang Ke; Yongke Zhang; Qiu Yu; Jonathan Lee; Mingzhen Li; Jialiang Song; Jungang Chen; Jihong Dai; Rebelo Do Couto, Fernando Jose; Zhiqiang An; Weimin Zhu; Guo-Liang Yu // PLoS ONE;2010, Vol. 5 Issue 2, p1 

    Rabbit antibodies have been widely used in research and diagnostics due to their high antigen specificity and affinity. Though these properties are also highly desirable for therapeutic applications, rabbit antibodies have remained untapped for human disease therapy. To evaluate the therapeutic...

  • Cloning and Sequencing of the VH and YK Genes of an Anti-CD3 Monoclonal Antibody, and Construction of a Mouse/Human Chimeric Antibody1. Arakawa, Fumiko; Kuroki, Masahide; Kuwahara, Motohisa; Senba, Tarumi; Ozaki, Hiroaki; Matsuoka, Yuji; Misumi, Yoshio; Kanda, Hidetoshi; Watanabe, Takeshi // Journal of Biochemistry;1996, Vol. 120 Issue 3, p657 

    Mouse monoclonal antibodies against CD3 on human T lymphocytes have been used for therapy in organ-transplant patients as a potent immunosuppressive agent or for treatment of cancer as a potent T cell activating agent. However, an inherent problem in their in vivo application is the human...

  • A Monoclonal Antibody, 3A10, Recognizes a Specific Amino Acid Sequence Present on a Series of Developmentally Expressed Brain Proteins. Harada, Ayako; Takeuchi, Ken-ichi; Dohmae, Naoshi; Takio, Koji; Uenaka, Toshimitu; Aoki, Junken; Inoue, Keizo; Umeda, Masato // Journal of Biochemistry;1999, Vol. 125 Issue 3, p443 

    Immunoblotting showed that a monoclonal antibody, 3A10, binds to a series of rat brain-specific antigens with molecular masses of 150-,120-,118-,106-,104-,79-, and 77-kDa. The expression of 3A10 antigens is dependent on the developmental stage of the brain; only the 106-kDa antigen is detected...

  • Application of monoclonal antibodies for the diagnostic and therapeutic targeting of human tumors with a necrotic component. Parseghian, M.; Mechetner, E.; Osidak, M.; Domogatskii, S. // Russian Journal of General Chemistry;Feb2014, Vol. 84 Issue 2, p345 

    Due to a unique structure of tumors, TNT antibodies can bind with a great number of target cells in the hypoxic core of the injury zone. Long-standing laboratory and clinical research gave evidence for the utility of histone/DNA complexes as stable insoluble antigens available for binding with...

  • Methionine Aminopeptidase II: A Molecular Chaperone for Sarcoplasmic Reticulum Calcium ATPase. Noguchi, Shunsuke; Komiya, Tohru; Eguchi, Hiroshi; Shirahata, Akira; Nikawa, Jun-ichi; Kawamura, Masaru // Journal of Membrane Biology;Feb2007, Vol. 215 Issue 2/3, p105 

    The monoclonal antibody to the β-subunit of H+/K+-ATPase (mAbHKβ) cross-reacts with a protein that acts as a molecular chaperone for the structural maturation of sarcoplasmic reticulum (SR) Ca2+-ATPase. We partially purified a mAbHKβ-reactive 65-kDa protein from Xenopus ovary. After...

  • CMC-544 (inotuzumab ozogamicin), an anti-CD22 immuno-conjugate of calicheamicin, alters the levels of target molecules of malignant B-cells. Takeshita, A.; Yamakage, N.; Shinjo, K.; Ono, T.; Hirano, I.; Nakamura, S.; Shigeno, K.; Tobita, T.; Maekawa, M.; Kiyoi, H.; Naoe, T.; Ohnishi, K.; Sugimoto, Y.; Ohno, R. // Leukemia (08876924);Jul2009, Vol. 23 Issue 7, p1329 

    We studied the effect of CMC-544, the calicheamicin-conjugated anti-CD22 monoclonal antibody, used alone and in combination with rituximab, analyzing the quantitative alteration of target molecules, that is, CD20, CD22, CD55 and CD59, in Daudi and Raji cells as well as in cells obtained from...

  • Distribution of high affinity choline transporter immunoreactivity in the primate central nervous system. Laura Kus; Ewa Borys; Ya Ping Chu; Shawn M. Ferguson; Randy D. Blakely; Marina E. Emborg; Jeffrey H. Kordower; Allan I. Levey; Elliott J. Mufson // Journal of Comparative Neurology;8/25/2003, Vol. 463 Issue 3, p341 

    A mouse monoclonal antibody (clone 62-2E8) raised against a human recombinant high-affinity choline transporter (CHT)-glutathione-S-transferase fusion protein was used to determine the distribution of immunoreactive profiles containing this protein in the monkey central nervous system (CNS)....

  • A Sensitive Monoclonal Antibody Sandwich ELISA for the Measurement of the Major Olive Pollen Allergen Ole e 1. van Ree, Ronald; Aalbers, Marja; Kea, Olga; Marco de la Calle, Francisco M.; Sempere Ortells, José M.; Villalba, Mayte; Rodriguez, Rosalia; Aalberse, Rob C. // International Archives of Allergy & Immunology;2000, Vol. 122 Issue 3, p224 

    Background: Olive pollen is a major cause of inhalant allergy in countries around the Mediterranean sea. The major allergen of olive pollen is Ole e 1. Measurement of the major allergen content of allergen products for diagnosis and therapy is becoming an essential element of standardization...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics